In-situ hybridization for beta4 integrin subunit in node-negative invasive carcinoma of the breast

被引：0
|
作者：
Diaz, LK [1 ]
Cristofanilli, M [1 ]
Zhou, X [1 ]
Welch, K [1 ]
Smith, TL [1 ]
Sneige, N [1 ]
Sahin, A [1 ]
Gilcrease, MZ [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
110
引用
收藏
页码：27A / 27A
页数：1
相关论文
共 50 条
  • [31] BETA-1 AND BETA-4 INTEGRIN EXPRESSION IN METHACARN AND FORMALIN-FIXED MATERIAL FROM IN-SITU DUCTAL CARCINOMA OF THE BREAST
    HANBY, AM
    GILLETT, CE
    PIGNATELLI, M
    STAMP, GWH
    JOURNAL OF PATHOLOGY, 1993, 171 (04): : 257 - 262
  • [32] CHROMOSOME-17 ANALYSIS OF DUCTAL CARCINOMA IN-SITU OF THE BREAST BY FLUORESCENCE IN-SITU HYBRIDIZATION
    MURPHY, DS
    GEORGE, WD
    KAYE, SB
    KEITH, WN
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1807 - 1807
  • [33] COMPARATIVE GENOMIC HYBRIDIZATION (CGH) PREDICTS RECURRENCE IN NODE-NEGATIVE BREAST-CANCER
    ISOLA, J
    CHU, L
    KALLIONIEMI, O
    FUQUA, S
    HILSENBECK, S
    CLARK, G
    OSBORNE, K
    WALDMAN, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 247 - 247
  • [34] HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
    Press, MF
    Bernstein, L
    Thomas, PA
    Meisner, LF
    Zhou, JY
    Ma, YL
    Hung, G
    Robinson, RA
    Harris, C
    ElNaggar, A
    Slamon, DJ
    Phillips, RN
    Ross, JS
    Wolman, SR
    Flom, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) : 2894 - 2904
  • [35] Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination -: Application to node-negative breast cancer
    Onody, P
    Bertrand, F
    Muzeau, F
    Bièche, I
    Lidereau, R
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2001, 125 (06) : 746 - 750
  • [36] MANAGEMENT OF IN-SITU AND MINIMALLY INVASIVE BREAST-CARCINOMA
    FRYKBERG, ER
    BLAND, KI
    WORLD JOURNAL OF SURGERY, 1994, 18 (01) : 45 - 57
  • [37] Ductal Carcinoma In-Situ Associated with Triple-Negative Invasive Breast Carcinoma Is Often Immunohistochemically Distinct from Invasive Component
    Simon, R. A.
    Karim, T. A.
    Zhang, C.
    Steinhoff, M. M.
    Sung, C. J.
    Quddus, M. R.
    CANCER RESEARCH, 2010, 70
  • [38] Lack of CD151/integrin alpha 3 beta 1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers
    Gong, Y.
    BREAST DISEASES, 2016, 27 (02): : 132 - 132
  • [39] ADJUVANT CHEMOTHERAPY AND ENDOCRINE THERAPY FOR NODE-POSITIVE AND NODE-NEGATIVE BREAST-CARCINOMA
    ALBAIN, KS
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1989, 32 (04): : 835 - 857
  • [40] Invasive breast cancer amplifies lymphangiogenic signals in tumor microenvironment through integrin beta4 expressing cancer-associated fibroblasts
    Kim, Baek Gil
    Choi, Yoon Pyo
    Kang, Suki
    Lee, Joo Hyun
    Cho, Nam Hoon
    CANCER RESEARCH, 2013, 73
12345